Advertisement

Disorders of Phenylalanine and Tetrahydrobiopterin Metabolism

  • Nenad Blau
  • Peter Burgard

Keywords

Folinic Acid Phenylalanine Hydroxylase COMT Inhibitor Health Consensus Development Plasma Phenylalanine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Academy of Pediatrics (2001) Maternal phenylketonuria. Pediatrics 107(2):427–8Google Scholar
  2. 2.
    Blau N, Erlandsen H (2004) The metabolic and molecular bases of tetrahydrobiopterinresponsive phenylalanine hydroxylase deficiency. Mol Genet Metab 82:101–111CrossRefPubMedGoogle Scholar
  3. 3.
    Blau N, Thöony B, Cotton RGH, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1725–1776Google Scholar
  4. 4.
    Brown AS, Fernhoff PM, Waisbren SE et al. (2002) Barriers to successful dietary control among pregnant women with phenylketonuria. Genet Med 4(2):84–9PubMedCrossRefGoogle Scholar
  5. 5.
    Burgard P, Bremer HJ, Buhrdel P et al. (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr 158(1):46–54CrossRefPubMedGoogle Scholar
  6. 6.
    Medical Research Council Working Party on Phenylketonuria (1993) Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68:426–427Google Scholar
  7. 7.
    National Institute of Health Consensus Development Panel (2001) National Institute of Health consensus development conference statement. Phenylketonuria: screening and management, 16—18 October 2000. Pediatrics 108:972–982Google Scholar
  8. 8.
    Ponzone A, Baglieri S, Battistoni G et al. (2001) Catechol-O-methyl transferase inhibitors in the treatment of inherited dopamine deficiency. Am J Hum Genet (Suppl. 1) 69:1072Google Scholar
  9. 9.
    Schuler A, Blau N, Ponzone A (1995) Monoamine oxidase inhibitors in tetrahydrobiopterin deficiency. Eur J Pediatr 154(12):997CrossRefPubMedGoogle Scholar
  10. 10.
    Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1667–1724Google Scholar
  11. 11.
    Spada M, Ferraris S, Ferrero GB et al. (1996) Monitoring treatment in tetrahydrobiopterin deficiency by serum prolactin. J Inherit Metab Dis 19(2):231–233CrossRefPubMedGoogle Scholar
  12. 12.
    Maternal Phenylketonuria Collaborative Study (2003) Pediatrics 112(6):1513–1587Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Nenad Blau
  • Peter Burgard

There are no affiliations available

Personalised recommendations